Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
10 01 2019
Historique:
received: 30 07 2018
accepted: 12 10 2018
pubmed: 18 10 2018
medline: 23 8 2019
entrez: 18 10 2018
Statut: ppublish

Résumé

Transposons impart dynamism to the genomes they inhabit and their movements frequently rewire the control of nearby genes. Occasionally, their proteins are domesticated when they evolve a new function. SETMAR is a protein methylase with a sequence-specific DNA binding domain. It began to evolve about 50 million years ago when an Hsmar1 transposon integrated downstream of a SET-domain methylase gene. Here we show that the DNA-binding domain of the transposase targets the enzyme to transposon-end remnants and that this is capable of regulating gene expression, dependent on the methylase activity. When SETMAR was modestly overexpressed in human cells, almost 1500 genes changed expression by more than 2-fold (65% up- and 35% down-regulated). These genes were enriched for the KEGG Pathways in Cancer and include several transcription factors important for development and differentiation. Expression of a similar level of a methylase-deficient SETMAR changed the expression of many fewer genes, 77% of which were down-regulated with no significant enrichment of KEGG Pathways. Our data is consistent with a model in which SETMAR is part of an anthropoid primate-specific regulatory network centered on the subset of genes containing a transposon end.

Identifiants

pubmed: 30329085
pii: 5133659
doi: 10.1093/nar/gky937
pmc: PMC6326780
doi:

Substances chimiques

DNA Transposable Elements 0
DNA-Binding Proteins 0
Histones 0
Transcription Factors 0
Histone Methyltransferases EC 2.1.1.-
Histone-Lysine N-Methyltransferase EC 2.1.1.43
SETMAR protein, human EC 2.1.1.43

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

122-133

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J014508/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J014508/1
Pays : United Kingdom

Références

Bioinformatics. 2011 Jun 15;27(12):1696-7
pubmed: 21486936
Annu Rev Genet. 2011;45:167-202
pubmed: 21854230
Mol Cell Biol. 2007 Feb;27(3):1125-32
pubmed: 17130240
Nat Commun. 2014 Jun 09;5:3965
pubmed: 24910128
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
PLoS Genet. 2014 Apr 10;10(4):e1004250
pubmed: 24721906
Oncotarget. 2017 Feb 7;8(6):9835-9848
pubmed: 28038463
PLoS Genet. 2012 Sep;8(9):e1002972
pubmed: 23028371
Biochemistry. 2015 Sep 8;54(35):5401-13
pubmed: 26292256
Oncotarget. 2015 Feb 10;6(4):2466-82
pubmed: 25537518
PLoS Genet. 2013 Apr;9(4):e1003470
pubmed: 23637635
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Biochimie. 2008 Sep;90(9):1422-6
pubmed: 18549821
Cell Rep. 2015 Feb 3;10(4):551-61
pubmed: 25640180
Mol Biol Evol. 2008 Jan;25(1):29-41
pubmed: 17940212
PLoS One. 2010 Jan 11;5(1):e8570
pubmed: 20084102
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
PLoS One. 2013 Dec 19;8(12):e83737
pubmed: 24367611
Nat Commun. 2016 Nov 14;7:13334
pubmed: 27841270
Nucleic Acids Res. 2008 Oct;36(18):5822-31
pubmed: 18790802
PLoS Genet. 2017 Feb 16;13(2):e1006632
pubmed: 28207814
Mol Gen Genet. 1992 Mar;232(1):126-34
pubmed: 1313144
Nature. 1980 Apr 17;284(5757):604-7
pubmed: 7366731
Biochim Biophys Acta. 2014 Dec;1839(12):1362-72
pubmed: 24560929
Nat Rev Genet. 2008 May;9(5):397-405
pubmed: 18368054
DNA Repair (Amst). 2012 May 1;11(5):488-501
pubmed: 22483866
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):540-5
pubmed: 21187428
PLoS One. 2015 Aug 25;10(8):e0136314
pubmed: 26305225
J Biol Chem. 2011 Mar 11;286(10):8361-8
pubmed: 21196496
Science. 2016 Mar 4;351(6277):1083-7
pubmed: 26941318
Nat Commun. 2014 Jun 09;5:4091
pubmed: 24909977
Nature. 2011 Jun 15;474(7351):337-42
pubmed: 21677750
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nature. 2000 Aug 10;406(6796):593-9
pubmed: 10949293
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8101-6
pubmed: 16672366
J Biol Chem. 2015 May 8;290(19):12040-7
pubmed: 25795785
Mol Cell Biol. 2007 Jun;27(12):4589-600
pubmed: 17403897
Microbiol Spectr. 2015 Apr;3(2):MDNA3-0033-2014.
pubmed: 26104691
Nat Genet. 2011 Sep 25;43(11):1154-9
pubmed: 21946353
PLoS One. 2014 Oct 15;9(10):e109741
pubmed: 25333365
Mol Ther. 2016 Mar;24(3):592-606
pubmed: 26755332
Nat Struct Mol Biol. 2016 Jun;23(6):540-8
pubmed: 27159561
Mol Cell. 2010 Apr 23;38(2):179-90
pubmed: 20417597
Nature. 2001 Feb 15;409(6822):860-921
pubmed: 11237011
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Nucleic Acids Res. 2010 Jul;38(13):4207-17
pubmed: 20215432
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18075-80
pubmed: 16332963
PLoS One. 2009;4(4):e5323
pubmed: 19390626
Trends Genet. 2017 Nov;33(11):817-831
pubmed: 28844698
PLoS Genet. 2012;8(11):e1003036
pubmed: 23166509
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Blood. 2009 Aug 27;114(9):1852-8
pubmed: 19458360
PLoS One. 2007 Feb 14;2(2):e203
pubmed: 17301878
Transcription. 2015;6(5):79-90
pubmed: 26399478
Nat Rev Mol Cell Biol. 2012 Jan 23;13(2):115-26
pubmed: 22266761
PLoS Genet. 2008 Mar 21;4(3):e1000031
pubmed: 18369450
EMBO J. 2011 Jan 19;30(2):328-40
pubmed: 21157429

Auteurs

Michael Tellier (M)

School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK.

Ronald Chalmers (R)

School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH